HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

tris(8- hydroxyquinoline)monochloroplatinum(II)

has antineoplastic activity; structure in first source

Also Known As:

tris(8-hydroxyquinoline)monochloroplatinum(II) chloride

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organometallic Compounds: 64
  - Organoplatinum Compounds
    - tris(8-hydroxyquinoline)monochloroplatinum(II): 1

Experts

1.	Arzuman, Laila: 1 article (12/2014)
2.	Beale, Philip: 1 article (12/2014)
3.	Huq, Fazlul: 1 article (12/2014)
4.	Proschogo, Nick: 1 article (12/2014)
5.	Yu, Jun Qing: 1 article (12/2014)

Related Diseases

1.

Neoplasms (Cancer)

12/01/2014 - "In this study, a new monofunctional planaramineplatinum(II) complex, namely tris(8-hydroxyquinoline)monochloroplatinum(II) chloride (coded as LH3), was synthesised and investigated for its activity against human ovarian A2780, cisplatin-resistant A2780 (A2780(cisR)) and ZD0473-resistant A2780 (A2780(ZD0473R)) cancer cell lines, alone and in combination with the phytochemicals curcumin, genistein and resveratrol. "

Related Drugs and Biologics

1.	Phytochemicals
2.	Genistein
3.	Curcumin
4.	Cisplatin (Platino)
5.	Resveratrol